191 related articles for article (PubMed ID: 25445420)
1. Comparison of toxicity experienced by older versus younger patients enrolled in breast cancer clinical trials.
Mariano C; Francl M; Pope J; Wong L; Lim HJ; Lohrisch C
Clin Breast Cancer; 2015 Feb; 15(1):73-9. PubMed ID: 25445420
[TBL] [Abstract][Full Text] [Related]
2. Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience.
Muss HB; Berry DA; Cirrincione C; Budman DR; Henderson IC; Citron ML; Norton L; Winer EP; Hudis CA;
J Clin Oncol; 2007 Aug; 25(24):3699-704. PubMed ID: 17704418
[TBL] [Abstract][Full Text] [Related]
3. Analysis of docetaxel therapy in elderly (≥70 years) castration resistant prostate cancer patients enrolled in the Netherlands Prostate Study.
Gerritse FL; Meulenbeld HJ; Roodhart JM; van der Velden AM; Blaisse RJ; Smilde TJ; Erjavec Z; de Wit R; Los M;
Eur J Cancer; 2013 Oct; 49(15):3176-83. PubMed ID: 23849828
[TBL] [Abstract][Full Text] [Related]
4. Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience.
De Maio E; Gravina A; Pacilio C; Amabile G; Labonia V; Landi G; Nuzzo F; Rossi E; D'Aiuto G; Capasso I; Rinaldo M; Morrica B; Elmo M; Di Maio M; Perrone F; de Matteis A
BMC Cancer; 2005 Mar; 5():30. PubMed ID: 15790416
[TBL] [Abstract][Full Text] [Related]
5. Elderly breast cancer patients: adjuvant chemotherapy and adjuvant endocrine therapy.
Biganzoli L; Aapro M
Gynakol Geburtshilfliche Rundsch; 2005 Jun; 45(3):137-42. PubMed ID: 15990438
[TBL] [Abstract][Full Text] [Related]
6. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of adverse events experienced by older patients participating in studies of molecularly targeted agents alone or in combination.
Townsley CA; Pond GR; Oza AM; Hirte HW; Winquist E; Goss G; Degendorfer P; Moore MJ; Siu LL
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2141-9. PubMed ID: 16609027
[TBL] [Abstract][Full Text] [Related]
8. [Effective treatment strategy in elderly breast cancer patients].
Boér K
Orv Hetil; 2005 Jan; 146(1):15-21. PubMed ID: 15715368
[TBL] [Abstract][Full Text] [Related]
9. [Therapy of breast carcinoma in elderly women].
Cianti C
Clin Ter; 1998; 149(6):439-46. PubMed ID: 10100407
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic therapy for the elderly with metastatic breast cancer: a review on safety, pharmacokinetics and efficacy.
Hamberg P; Verweij J; Seynaeve C
Eur J Cancer; 2007 Jul; 43(10):1514-28. PubMed ID: 17482454
[TBL] [Abstract][Full Text] [Related]
11. The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly.
Schild SE; Stella PJ; Geyer SM; Bonner JA; McGinnis WL; Mailliard JA; Brindle J; Jatoi A; Jett JR;
J Clin Oncol; 2003 Sep; 21(17):3201-6. PubMed ID: 12874270
[TBL] [Abstract][Full Text] [Related]
12. Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials.
Gianni L; Panzini I; Li S; Gelber RD; Collins J; Holmberg SB; Crivellari D; Castiglione-Gertsch M; Goldhirsch A; Coates AS; Ravaioli A;
Cancer; 2006 Feb; 106(3):505-13. PubMed ID: 16369994
[TBL] [Abstract][Full Text] [Related]
13. Elderly ovarian cancer patients: An individual participant data meta-analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO).
Woopen H; Inci G; Richter R; Chekerov R; Ismaeel F; Sehouli J
Eur J Cancer; 2016 Jun; 60():101-6. PubMed ID: 27104667
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant treatment for breast cancer in the elderly.
Marchei P; Bianco V; Pignatelli E; Chiodini S; Santini D; Carico E; Marchei M; Vecchione A
Anticancer Res; 1996; 16(2):911-3. PubMed ID: 8687150
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
16. Elderly patients benefit from second-line cytotoxic chemotherapy: a subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients with previously treated advanced non-small-cell lung cancer.
Weiss GJ; Langer C; Rosell R; Hanna N; Shepherd F; Einhorn LH; Nguyen B; Paul S; McAndrews P; Bunn PA; Kelly K
J Clin Oncol; 2006 Sep; 24(27):4405-11. PubMed ID: 16983108
[TBL] [Abstract][Full Text] [Related]
17. [Anticancer chemotherapy in the elderly: a review of the literature].
Debrix I; Avenin D; André T; Abbas F; Gligorov J; Milleron B; Lotz JP; Becker A
Bull Cancer; 2008 May; 95 FMC Onco():F37-43. PubMed ID: 18511365
[TBL] [Abstract][Full Text] [Related]
18. Advanced non-small-cell lung cancer in the elderly.
Vamvakas L; Saloustros E; Karampeazis A; Georgoulias V
Clin Lung Cancer; 2009 May; 10(3):158-67. PubMed ID: 19443335
[TBL] [Abstract][Full Text] [Related]
19. nab-Paclitaxel in combination with biologically targeted agents for early and metastatic breast cancer.
Megerdichian C; Olimpiadi Y; Hurvitz SA
Cancer Treat Rev; 2014 Jun; 40(5):614-25. PubMed ID: 24560997
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer in older women.
Muss HB
Semin Oncol; 1996 Feb; 23(1 Suppl 2):82-8. PubMed ID: 8614851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
